Cargando…
Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome
INTRODUCTION: Leukemia is the most common malignancy of childhood but myeloid sarcoma is a rare presentation of underlying leukemic disorder. Myeloid sarcoma (MS) is a rare tumor composed of proliferation of myeloid precursors at extramedullary sites. PRESENTATION OF CASE: We report an unusual case...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479101/ https://www.ncbi.nlm.nih.gov/pubmed/31015077 http://dx.doi.org/10.1016/j.ijscr.2019.03.027 |
_version_ | 1783413277018030080 |
---|---|
author | Marwah, Nisha Bhutani, Namita Budhwar, Archana Sen, Rajeev |
author_facet | Marwah, Nisha Bhutani, Namita Budhwar, Archana Sen, Rajeev |
author_sort | Marwah, Nisha |
collection | PubMed |
description | INTRODUCTION: Leukemia is the most common malignancy of childhood but myeloid sarcoma is a rare presentation of underlying leukemic disorder. Myeloid sarcoma (MS) is a rare tumor composed of proliferation of myeloid precursors at extramedullary sites. PRESENTATION OF CASE: We report an unusual case of myeloid sarcoma involving the temporal bone in a young male child who presented with a large mass involving the left temporal region. This lesion was the initial presentation which led to further diagnosis of acute myeloid leukemia in our case. This case report brings awareness to the diverse extramedullary manifestations of isolated myeloid sarcoma, as well as the importance and difficulties that are associated with establishing a rapid diagnosis and initiating treatment. DISCUSSION: They can arise de novo or in association with hematological malignancies, most commonly acute myeloid leukemia (AML-M2). Clinically, it can masquerade as an abscess, cutaneous ulcer, or as a mass lesion. Morphologically, MS can mimic a variety of small round cell tumors including lymphomas, neuroblatoma and rhabdomyosarcoma. The occurrence of this tumor usually heralds AML or the onset of the blastic phase of chronic myeloid leukemia. Early recognition of this rare entity is important, because early aggressive chemotherapy and focal irradiation can cause regression of the tumor and thus improve patient longevity. CONCLUSION: The possibility of MS should be considered when dealing with unusual lymphoma like neoplasms that cannot be categorized as any of the Non-Hodgkin lymphoma subtypes and small blue round cell tumors. |
format | Online Article Text |
id | pubmed-6479101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-64791012019-05-02 Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome Marwah, Nisha Bhutani, Namita Budhwar, Archana Sen, Rajeev Int J Surg Case Rep Article INTRODUCTION: Leukemia is the most common malignancy of childhood but myeloid sarcoma is a rare presentation of underlying leukemic disorder. Myeloid sarcoma (MS) is a rare tumor composed of proliferation of myeloid precursors at extramedullary sites. PRESENTATION OF CASE: We report an unusual case of myeloid sarcoma involving the temporal bone in a young male child who presented with a large mass involving the left temporal region. This lesion was the initial presentation which led to further diagnosis of acute myeloid leukemia in our case. This case report brings awareness to the diverse extramedullary manifestations of isolated myeloid sarcoma, as well as the importance and difficulties that are associated with establishing a rapid diagnosis and initiating treatment. DISCUSSION: They can arise de novo or in association with hematological malignancies, most commonly acute myeloid leukemia (AML-M2). Clinically, it can masquerade as an abscess, cutaneous ulcer, or as a mass lesion. Morphologically, MS can mimic a variety of small round cell tumors including lymphomas, neuroblatoma and rhabdomyosarcoma. The occurrence of this tumor usually heralds AML or the onset of the blastic phase of chronic myeloid leukemia. Early recognition of this rare entity is important, because early aggressive chemotherapy and focal irradiation can cause regression of the tumor and thus improve patient longevity. CONCLUSION: The possibility of MS should be considered when dealing with unusual lymphoma like neoplasms that cannot be categorized as any of the Non-Hodgkin lymphoma subtypes and small blue round cell tumors. Elsevier 2019-03-28 /pmc/articles/PMC6479101/ /pubmed/31015077 http://dx.doi.org/10.1016/j.ijscr.2019.03.027 Text en © 2019 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Marwah, Nisha Bhutani, Namita Budhwar, Archana Sen, Rajeev Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome |
title | Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome |
title_full | Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome |
title_fullStr | Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome |
title_full_unstemmed | Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome |
title_short | Isolated myeloid sarcoma of the temporal bone: As the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome |
title_sort | isolated myeloid sarcoma of the temporal bone: as the first clinical manifestation of acute myeloid leukemia in a patient of down’s syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479101/ https://www.ncbi.nlm.nih.gov/pubmed/31015077 http://dx.doi.org/10.1016/j.ijscr.2019.03.027 |
work_keys_str_mv | AT marwahnisha isolatedmyeloidsarcomaofthetemporalboneasthefirstclinicalmanifestationofacutemyeloidleukemiainapatientofdownssyndrome AT bhutaninamita isolatedmyeloidsarcomaofthetemporalboneasthefirstclinicalmanifestationofacutemyeloidleukemiainapatientofdownssyndrome AT budhwararchana isolatedmyeloidsarcomaofthetemporalboneasthefirstclinicalmanifestationofacutemyeloidleukemiainapatientofdownssyndrome AT senrajeev isolatedmyeloidsarcomaofthetemporalboneasthefirstclinicalmanifestationofacutemyeloidleukemiainapatientofdownssyndrome |